T1 mapping of the gadolinium-enhanced myocardium: adjustment for factors affecting interpatient comparison.
about
Normal values for cardiovascular magnetic resonance in adults and childrenTissue characterization of the myocardium: state of the art characterization by magnetic resonance and computed tomography imagingEmerging MRI methods in translational cardiovascular researchDiagnostic and prognostic value of cardiovascular magnetic resonance in non-ischaemic cardiomyopathies.Cardiac imaging techniques for physicians: late enhancementT1-mapping in the heart: accuracy and precisionDetermination of location, size, and transmurality of chronic myocardial infarction without exogenous contrast media by using cardiac magnetic resonance imaging at 3 TAssociation of longitudinal changes in left ventricular structure and function with myocardial fibrosis: the Multi-Ethnic Study of Atherosclerosis study.Progression of diffuse myocardial fibrosis assessed by cardiac magnetic resonance T₁ mapping.Reference values for healthy human myocardium using a T1 mapping methodology: results from the International T1 Multicenter cardiovascular magnetic resonance study.Multi-parametric MRI as an indirect evaluation tool of the mechanical properties of in-vitro cardiac tissues.Extracellular volume fraction is more closely associated with altered regional left ventricular velocities than left ventricular ejection fraction in nonischemic cardiomyopathy.Assessment of myocardial fibrosis with cardiovascular magnetic resonance.Cardiac MR imaging to probe tissue composition of the heart by using T1 mapping.Myocardial T1 mapping: techniques and potential applications.Myocardial T1 mapping with MRI: comparison of look-locker and MOLLI sequences.Evaluation of post-contrast myocardial t1 in duchenne muscular dystrophy using cardiac magnetic resonance imaging.Myocardial T1 and extracellular volume fraction mapping at 3 tesla.Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy.T1 mapping of the myocardium: intra-individual assessment of post-contrast T1 time evolution and extracellular volume fraction at 3T for Gd-DTPA and Gd-BOPTA.Extracellular volume fraction mapping in the myocardium, part 1: evaluation of an automated method.Assessment of cardiac involvement in myotonic muscular dystrophy by T1 mapping on magnetic resonance imaging.The protein binding substance ibuprofen does not affect the T1 time or partition coefficient in contrast-enhanced cardiovascular magnetic resonanceT1 Mapping in cardiomyopathy at cardiac MR: comparison with endomyocardial biopsy.Dose correction for post-contrast T1 mapping of the heart: the MESA study.Diffuse myocardial fibrosis evaluation using cardiac magnetic resonance T1 mapping: sample size considerations for clinical trials.Cardiac magnetic resonance T1 mapping of left atrial myocardium.Evaluation of age-related interstitial myocardial fibrosis with cardiac magnetic resonance contrast-enhanced T1 mapping: MESA (Multi-Ethnic Study of Atherosclerosis).Associations between fibrocytes and postcontrast myocardial T1 times in hypertrophic cardiomyopathy.Myocardial T1 and T2 Mapping: Techniques and Clinical Applications.Optimization and comparison of myocardial T1 techniques at 3T in patients with aortic stenosis.Myocardial T1 mapping: modalities and clinical applications.Advanced Cardiac MR Imaging for Myocardial Characterization and Quantification: T1 MappingCardiac MRI: a central prognostic tool in myocardial fibrosis.Imaging-guided Ventricular Tachycardia Ablation.Glucose targets for preventing diabetic kidney disease and its progression.Correlation between right ventricular T1 mapping and right ventricular dysfunction in non-ischemic cardiomyopathy.T1 Mapping for Myocardial Fibrosis by Cardiac Magnetic Resonance Relaxometry-A Comprehensive Technical Review.Association of Cardiovascular Risk Factors and Myocardial Fibrosis With Early Cardiac Dysfunction in Type 1 Diabetes: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study.Cardiac remodelling identified by cardiovascular magnetic resonance in patients with hepatitis C infection and liver disease.
P2860
Q26998833-B6015774-38C8-40F9-B6AE-8EB183AEB0AEQ27003231-4D72BAF3-A817-435F-BA9D-125BE91D3A4FQ30425743-2C5A7753-D020-4BD1-9FB2-7639828FF4BBQ30463822-7C5469F4-D101-40EC-B1B0-91AEB96BF03DQ30558233-FE7164B3-5B90-491C-90C6-8831EA1DC766Q30725831-DF54144A-D968-4D09-9B9F-3011AB5861D6Q33830977-897305BB-2AF0-4448-8712-07191D564BC9Q34051551-C6323215-EA16-4186-8FA5-0CAD3A61EDA9Q34216754-EF7F186D-64C4-420A-927B-3B39B052497CQ34374909-ABA7064C-302F-4D9D-AB8C-910E77D77E65Q34640509-35455616-F3D7-4023-857C-E4D90594EB2BQ34817378-67BCBDE5-0E5C-4634-8DA4-C0979D276026Q34846884-16A32CF6-174C-46BB-A4C2-B72D02C1D9C0Q35174316-8E529593-F645-4909-BB35-FA9F4A0F6796Q35174325-9ACC4BF0-2B1A-4322-BDBD-1D3BB86D122EQ35566375-DB50020F-8388-45CF-ABA6-0F71D44C15F5Q35629034-981869C0-682C-4D35-8B76-98C2027F465CQ35717240-C2DC8D1C-CF8A-4DDA-9B9A-38F05AEC8274Q36088154-260485F2-E7C8-41F1-8DEB-F098FEB86A5EQ36118231-5D0461C6-1E63-436C-B8B9-AE0088601C94Q36233097-6856F716-FBB5-403F-B259-EDCD4FB44422Q36282231-5EF3BA7D-9FF1-4838-B60F-29A11A169391Q36406587-058D0D8F-1B3D-4E19-9F33-B978B5059568Q36417705-168E0D9F-6A8A-4D82-8616-11542D11D14EQ36540551-9E44307A-E63F-4BE8-96F6-721AB0388C31Q36555925-6871C27D-0BCB-4ACA-B4F5-B9094227D323Q37131859-C641D6D0-48EE-4202-87EA-80152839B76BQ37254072-FBC99EC7-55DB-48D1-B651-52C81C8DA7A8Q37328738-F39867D6-5500-45CC-87A0-9121A63CF9FAQ37589574-7DEF7022-F57A-43F8-BCFE-E3ABA5E26617Q37691774-0ABCB8F0-66F9-426A-AA1C-C9DC76831029Q37717684-FB2F99CC-B804-4F41-A060-2F77EF8592B7Q38081414-65ACCE06-4229-4DFB-B396-110BC4E38C07Q38263089-E32327F1-CC64-4598-BE19-45247F566159Q38719247-38CF90F6-DF81-4A84-AFE4-298800986709Q38736800-AC2FC0ED-DE88-4894-BA19-EEC630E124C5Q38867726-2D37825D-6802-4E39-9095-84323DB55C94Q39210161-2B4C6A4F-09B0-4D36-A37F-209A1E460D76Q40420450-5DD54DAF-931A-432D-BFBF-B21C6722F9DCQ40871375-12ABEB90-DDFB-4C46-9EFF-893F3A30402D
P2860
T1 mapping of the gadolinium-enhanced myocardium: adjustment for factors affecting interpatient comparison.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
T1 mapping of the gadolinium-e ...... cting interpatient comparison.
@ast
T1 mapping of the gadolinium-e ...... cting interpatient comparison.
@en
T1 mapping of the gadolinium-e ...... cting interpatient comparison.
@nl
type
label
T1 mapping of the gadolinium-e ...... cting interpatient comparison.
@ast
T1 mapping of the gadolinium-e ...... cting interpatient comparison.
@en
T1 mapping of the gadolinium-e ...... cting interpatient comparison.
@nl
prefLabel
T1 mapping of the gadolinium-e ...... cting interpatient comparison.
@ast
T1 mapping of the gadolinium-e ...... cting interpatient comparison.
@en
T1 mapping of the gadolinium-e ...... cting interpatient comparison.
@nl
P2093
P2860
P356
P1476
T1 mapping of the gadolinium-e ...... cting interpatient comparison.
@en
P2093
Chia-Ying Liu
Evrim B Turkbey
João A C Lima
Neville Gai
Rob J van der Geest
Saman Nazarian
P2860
P304
P356
10.1002/MRM.22716
P577
2010-12-16T00:00:00Z